Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.38 +0.20 (+6.29%)
At close: Sep 29, 2026 · 4:00 PM EDT

Insight Molecular Diagnostics (IMDX) Acquisitions (2020 - 2021)

Updated

Insight Molecular Diagnostics (IMDX) posted Acquisitions of $607,000 for FY2021, down 90.2% from $6.19 million in FY2020.

Analysis

Insight Molecular Diagnostics (IMDX) Acquisitions (2020 - 2021) Analysis & Trends

  • Business Quant data shows IMDX's Acquisitions at $6.19 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn -
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn -
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn -
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn -
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 1.16 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 437.00 Mn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 195.00 Mn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 22.00 Mn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 7.10 Mn
10 Insight Molecular Diagnostics 103.74 Mn 27.46 Mn 157,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 607,000.00
Mar 31, 2020 6.19 Mn
API Access

Insight Molecular Diagnostics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=IMDX&period=max&api_key=YOUR_API_KEY